Earnings Ahead

STIM - Neuronetics, Inc.

2.08 -0.065 -3.03

Neuronetics, Inc.

Neuronetics, Inc.

About

Profile


Headquarters

Malvern, Pennsylvania, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

STIM



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Neuronetics GAAP EPS of -$0.33 misses by $0.02, revenue of $17.9M beats by $0.32M
  • Neuronetics draws down remaining $22.5M under credit facility
  • Neuronetics GAAP EPS of -$0.17 beats by $0.17, revenue of $17.6M beats by $0.14M
  • Neuronetics GAAP EPS of -$0.38 beats by $0.01, revenue of $15.54M beats by $0.37M
  • Neuronetics names Lisa Metzner-Rosas as CMO
  • Neuronetics secures up to $60M in new debt financing with SLR capital partners
  • Neuronetics GAAP EPS of -$0.30 beats by $0.08, revenue of $18.2M beats by $0.2M
  • Neuronetics and Greenbrook ink six-year deal for depression treatment
  • BrainsWay resolves unfair competition litigation with Neuronetics
  • Neuronetics GAAP EPS of -$0.28 beats by $0.14, revenue of $16.5M beats by $1.48M
  • Neuronetics gets FDA nod for its D-Tect accessory product for use to treat depression
  • Neuronetics GAAP EPS of -$0.39 beats by $0.02, revenue of $16.3M beats by $0.84M , revises FY guidance
  • Neuronetics stock soars 30% as FDA clears NeuroStar system for anxious depression
  • Neuronetics GAAP EPS of -$0.41 misses by $0.01, revenue of $14.18M beats by $0.72M
  • Neuronetics expands commercial partnership with Transformations Care Network
  • Neuronetics gains on FDA clearance for NeuroStar in OCD
  • Neuronetics GAAP EPS of -$0.29 beats by $0.03, revenue of $15.02M beats by $0.58M
  • Neuronetics amends credit facility with SLR Investment
  • Neuronetics higher on seeing Q4 and FY2021 revenue above consensus
  • Neuronetics' MT Cap technology for NeuroStar therapy receives 510(k) clearance

Earnings History

Date EPS / Forecast Revenue / Forecast
November 9, 2021 -0.31 / -0.3023 13.79M / 14.1M
August 3, 2021 -0.29 / -0.2399 14.2M / 14.72M
May 4, 2021 -0.31 / -0.3105 12.29M / 11.57M Beat!
March 2, 2021 -0.19 / -0.2409 15.58M / 14.41M Beat!
November 2, 2020 -0.18 / -0.282 12.45M / 11.23M Beat!
August 4, 2020 -0.41 / -0.52 9.74M / 8.22M Beat!
May 5, 2020 -0.68 / -0.5 11.48M / 13.03M
March 3, 2020 -0.41 / -0.44 17.36M / 16.95M Beat!
November 5, 2019 -0.37 / -0.43 16M / 16.19M
August 6, 2019 -0.39 / -0.41 16.57M / 15.8M Beat!
May 7, 2019 -0.42 / -0.4 12.73M / 12.69M Beat!
March 5, 2019 -0.35 / -0.36 15.64M / 14.9M Beat!
November 6, 2018 -0.23 / - 10.49M / - Beat!
August 14, 2018 -0.18 / - 10.31M / - Beat!
Date Price Open High Low Vol Change ER
May 26, 2023 2.92 2.8
3.09
2.76
201K 6.18%
May 25, 2023 2.75 2.74
2.77
2.57
101K -1.08%
May 24, 2023 2.78 2.69
2.78
2.6
100K 2.58%
May 23, 2023 2.71 2.71
2.84
2.53
69.2K -1.09%
May 22, 2023 2.74 2.72
2.8
2.57
129K 1.11%
 
May 19, 2023 2.71 2.58
2.74
2.53
128K 5.45%
May 18, 2023 2.57 2.75
2.76
2.5
122K -6.88%
May 17, 2023 2.76 2.72
2.97
2.64
171K 2.22%
May 16, 2023 2.7 2.82
2.83
2.68
41.6K -4.26%
May 15, 2023 2.82 2.78
2.83
2.6
64.8K 1.44%
May 12, 2023 2.78 2.75
2.87
2.6
120K 1.46%
May 11, 2023 2.74 2.85
2.85
2.64
103K -2.49%
May 10, 2023 2.81 2.84
3.14
2.8
325K 0.36%
May 9, 2023 2.8 2.49
3.18
2.46
1.4M 27.27%
May 8, 2023 2.2 2.3
2.38
2.16
191K -3.08%
May 5, 2023 2.27 2.26
2.32
2.2
67.4K 0.89%
May 4, 2023 2.25 2.2
2.31
2.17
94.5K 0%
May 3, 2023 2.25 2.26
2.31
2.21
42.7K 0%
May 2, 2023 2.25 2.3
2.33
2.16
131K -2.17%
May 1, 2023 2.3 2.27
2.37
2.25
100K 0.44%
Apr 28, 2023 2.29 2.28
2.33
2.19
518K 1.33%
Apr 27, 2023 2.26 2.24
2.3
2.18
251K 1.35%
Apr 26, 2023 2.23 2.24
2.3
2.21
116K 0%
Apr 25, 2023 2.23 2.2
2.26
2.2
95.6K 0.45%
Apr 24, 2023 2.22 2.2
2.24
2.12
154K 0.91%
Apr 21, 2023 2.2 2.17
2.24
2.15
94.9K 1.85%
Apr 20, 2023 2.16 2.15
2.21
2.13
105K -0.92%
Apr 19, 2023 2.18 2.06
2.19
2.06
126K 5.31%
Apr 18, 2023 2.07 2.16
2.17
2.01
104K -4.61%
Apr 17, 2023 2.17 2.2
2.23
2.15
80.8K -2.25%
Apr 14, 2023 2.22 2.3
2.35
2.18
105K -3.9%
Apr 13, 2023 2.31 2.37
2.42
2.27
142K -2.12%
Apr 12, 2023 2.36 2.49
2.53
2.31
145K -4.45%
Apr 11, 2023 2.47 2.44
2.61
2.44
155K 1.23%
Apr 10, 2023 2.44 2.31
2.49
2.26
219K 5.17%
Apr 6, 2023 2.32 2.57
2.57
2.23
973K -9.38%
Apr 5, 2023 2.56 2.7
2.72
2.53
118K -4.83%
Apr 4, 2023 2.69 2.67
2.76
2.63
122K 2.28%
Apr 3, 2023 2.63 2.92
2.92
2.57
250K -9.62%
Mar 31, 2023 2.91 2.93
2.94
2.75
147K 0%
Mar 30, 2023 2.91 2.95
3.02
2.87
67.3K -0.34%
Mar 29, 2023 2.92 2.92
3.01
2.86
87.3K 2.10%
Mar 28, 2023 2.86 2.94
2.99
2.85
86.0K -2.39%
Mar 27, 2023 2.93 2.87
2.99
2.87
103K 4.27%
Mar 24, 2023 2.81 2.95
3.01
2.65
216K -4.1%
Mar 23, 2023 2.93 2.97
3.18
2.85
273K 0.34%
Mar 22, 2023 2.92 3.2
3.32
2.92
144K -7.59%
Mar 21, 2023 3.16 3.03
3.19
2.97
95.7K 9.72%
Mar 20, 2023 2.88 2.83
2.9
2.71
258K 1.77%
Mar 17, 2023 2.83 2.93
3.06
2.82
192K -4.39%
Mar 16, 2023 2.96 3.1
3.21
2.87
808K -3.27%
Mar 15, 2023 3.06 2.94
3.11
2.92
163K 0.66%
Mar 14, 2023 3.04 2.96
3.1
2.9
380K 4.11%
Mar 13, 2023 2.92 3.21
3.28
2.92
425K -7.89%
Mar 10, 2023 3.17 3.5
3.58
2.95
1.1M -9.69%
Mar 9, 2023 3.51 3.77
3.97
3.43
780K -6.4%
Mar 8, 2023 3.75 4.18
4.25
3.62
1.0M -10.93%
Mar 7, 2023 4.21 4.76
4.76
4.12
704K -19.19%
Mar 6, 2023 5.21 5.27
5.42
5.08
120K -1.14%
Mar 3, 2023 5.27 5.52
5.62
5.1
423K 0%